药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Saprisartan
Asunaprevir
The metabolism of Asunaprevir can be decreased when combined with Cobicistat.
Saprisartan
Elbasvir
The metabolism of Elbasvir can be decreased when combined with Cobicistat.
Saprisartan
Paritaprevir
The metabolism of Paritaprevir can be decreased when combined with Cobicistat.
Saprisartan
Benidipine
The metabolism of Benidipine can be decreased when combined with Cobicistat.
Saprisartan
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Cobicistat.
Saprisartan
Perampanel
The metabolism of Perampanel can be decreased when combined with Cobicistat.
Saprisartan
Artemether
The metabolism of Artemether can be decreased when combined with Cobicistat.
Saprisartan
Vicriviroc
The metabolism of Vicriviroc can be decreased when combined with Cobicistat.
Saprisartan
Udenafil
The metabolism of Udenafil can be decreased when combined with Cobicistat.
Saprisartan
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Cobicistat.
Saprisartan
Sonidegib
The metabolism of Sonidegib can be decreased when combined with Cobicistat.
Saprisartan
Alectinib
The metabolism of Alectinib can be decreased when combined with Cobicistat.
Saprisartan
Thiotepa
The metabolism of Thiotepa can be decreased when combined with Cobicistat.
Saprisartan
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Cobicistat.
Saprisartan
Tianeptine
The metabolism of Tianeptine can be decreased when combined with Cobicistat.
Saprisartan
Midostaurin
The metabolism of Cobicistat can be decreased when combined with Midostaurin.
Saprisartan
Ivosidenib
The metabolism of Ivosidenib can be decreased when combined with Cobicistat.
Saprisartan
Baricitinib
The metabolism of Baricitinib can be decreased when combined with Cobicistat.
Saprisartan
Vinflunine
The metabolism of Vinflunine can be decreased when combined with Cobicistat.
Saprisartan
Venetoclax
The metabolism of Venetoclax can be decreased when combined with Cobicistat.